AstraZeneca Zomig on VA/DoD formulary

Executive Summary

AstraZeneca's Zomig (zolmitriptan) will be sole triptan on formulary of the Departments of Defense and Veteran Affairs effective July 11. AstraZeneca won the contract by offering a price of $3.20 per tablet, 57% less than Zomig's cheapest price on the Federal Supply Schedule ($44.21 for a six tablet pack of Zomig-ZMT 2.5 mg). The departments had also been considering Pharmacia's - now Ortho-McNeil's - Axert (almotriptan), GlaxoSmithKline's Imitrex (sumatriptan) and Merck's Maxalt (rizatriptan) (1"The Pink Sheet" April 14, 2003, p. 25)...